Search Results - "Hoyos, Valentina"

Refine Results
  1. 1

    Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects by Shafer, Paul, Kelly, Lauren M, Hoyos, Valentina

    Published in Frontiers in immunology (03-03-2022)
    “…To redirect T cells against tumor cells, T cells can be engineered to express cancer-antigen specific T cell receptors (TCRs), generating products known as…”
    Get full text
    Journal Article
  2. 2

    Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1 by Chen, Nan, Higashiyama, Nicole, Hoyos, Valentina

    Published in Biomedicines (08-12-2021)
    “…Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now widely applied across numerous malignancies. Pembrolizumab has two…”
    Get full text
    Journal Article
  3. 3
  4. 4

    CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation by Bajgain, Pradip, Tawinwung, Supannikar, D'Elia, Lindsey, Sukumaran, Sujita, Watanabe, Norihiro, Hoyos, Valentina, Lulla, Premal, Brenner, Malcolm K, Leen, Ann M, Vera, Juan F

    Published in Journal for immunotherapy of cancer (10-05-2018)
    “…The adoptive transfer of T cells redirected to tumor via chimeric antigen receptors (CARs) has produced clinical benefits for the treatment of hematologic…”
    Get full text
    Journal Article
  5. 5

    Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells by YVON, Eric, DEL VECCHIO, Michele, SAVOLDO, Barbara, HOYOS, Valentina, DUTOUR, Aurélie, ANICHINI, Andrea, DOTTI, Gianpietro, BRENNER, Malcolm K

    Published in Clinical cancer research (15-09-2009)
    “…Purpose: Genetic engineering of human T lymphocytes to express tumor-directed chimeric antigen receptors (CAR) can produce antitumor effector cells that bypass…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Genetic modification of human T lymphocytes for the treatment of hematologic malignancies by HOYOS, Valentina, SAVOLDO, Barbara, DOTTI, Gianpietro

    Published in Haematologica (Roma) (01-11-2012)
    “…Modern chemotherapy regimens and supportive care have produced remarkable improvements in the overall survival of patients with hematologic malignancies…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases by Higashiyama, Nicole, Nangia, Julie, Shafaee, Maryam Nemati, Chen, Nan, Michael, Binu Liz, Rimawi, Mothaffar, Hoyos, Valentina

    Published in Current problems in cancer. Case reports (01-12-2020)
    “…Trastuzumab deruxtecan has been shown to have responses in heavily pretreated patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic…”
    Get full text
    Journal Article
  11. 11

    Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch by Yagyu, Shigeki, Hoyos, Valentina, Del Bufalo, Francesca, Brenner, Malcolm K

    “…Expression of the inducible caspase-9 (iC9) suicide gene is one of the most appealing safety strategies for cell therapy and has been applied for human-induced…”
    Get full text
    Journal Article
  12. 12

    The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies by Hoyos, Valentina, Borrello, Ivan

    Published in Blood (29-09-2016)
    “…The treatment of multiple myeloma has evolved significantly over the last decades from primarily alkylator-based chemotherapeutic agents with minimal efficacy…”
    Get full text
    Journal Article
  13. 13

    Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes by Caruana, Ignazio, Savoldo, Barbara, Hoyos, Valentina, Weber, Gerrit, Liu, Hao, Kim, Eugene S, Ittmann, Michael M, Marchetti, Dario, Dotti, Gianpietro

    Published in Nature medicine (01-05-2015)
    “…Gianpietro Dotti and colleagues report that CAR-T cells expressing heparanase to degrade the extracellular matrix may enhance their infiltration of and effects…”
    Get full text
    Journal Article
  14. 14

    Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors by Nishio, Nobuhiro, Diaconu, Iulia, Liu, Hao, Cerullo, Vincenzo, Caruana, Ignazio, Hoyos, Valentina, Bouchier-Hayes, Lisa, Savoldo, Barbara, Dotti, Gianpietro

    Published in Cancer research (Chicago, Ill.) (15-09-2014)
    “…The clinical efficacy of chimeric antigen receptor (CAR)-redirected T cells remains marginal in solid tumors compared with leukemias. Failures have been…”
    Get full text
    Journal Article
  15. 15

    Crisis en el sistema de fuentes del derecho internacional: el SOFT LAW en el derecho penal internacional y el derecho penal colombiano by Gómez Pavajeau, Carlos Arturo, Hoyos Otálvaro, Valentina, Posada Martínez, Martín

    Published in Derecho penal y criminología (01-01-2022)
    “…El soft law es una fuente del derecho internacional que influye en el derecho penal internacional y en el sistema penal colombiano. La evolución del derecho…”
    Get full text
    Journal Article
  16. 16

    Abstract P2-08-14: Effect of markers of systemic inflammation on tumor infiltrating lymphocytes in patients with non-metastatic triple negative and HER2+ breast cancer: A single center retrospective study by Chen, Nan, Bulsara, Shaun, Hilsenbeck, Susan, Hoyos, Valentina

    Published in Cancer research (Chicago, Ill.) (15-02-2022)
    “…Abstract Background: Tumor infiltrating lymphocytes (TILs) are increasingly being recognized as a vital component of the tumor immune microenvironment. TILs…”
    Get full text
    Journal Article
  17. 17

    An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells by Yagyu, Shigeki, Hoyos, Valentina, Del Bufalo, Francesca, Brenner, Malcolm K

    Published in Molecular therapy (01-09-2015)
    “…Human induced pluripotent stem cells (hiPSC) hold promise for regenerative therapies, though there are several safety concerns including the risk of oncogenic…”
    Get full text
    Journal Article
  18. 18

    Frequency of coprescription and potential risk of bronchospasm in Colombian patients users of topical antiglaucomatous betablockers and bronchodilators by Machado-Alba, Jorge Enrique, Hoyos-Soto, Valentina

    Published in Vitae (Medellín) (21-07-2014)
    “…Background: Cardiovascular and respiratory effects of adrenergic agonists used in diseases like chronic obstructive pulmonary disease (COPD), and β-blockers…”
    Get full text
    Journal Article
  19. 19

    Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity by McKenna, Mary K., Englisch, Alexander, Brenner, Benjamin, Smith, Tyler, Hoyos, Valentina, Suzuki, Masataka, Brenner, Malcolm K.

    Published in Molecular therapy (05-05-2021)
    “…The immunosuppressive tumor microenvironment (TME) is a formidable barrier to the success of adoptive cell therapies for solid tumors. Oncolytic immunotherapy…”
    Get full text
    Journal Article
  20. 20

    Toxicidad sistemica por anestesicos locales by Quintana Puerta, Julian Esteban, Cifuentes Hoyos, Valentina

    Published in C.E.S. medicina (01-01-2014)
    “…Los anestésicos locales son medicamentos de uso generalizado y, aunque se consideran seguros, ocasionalmente pueden producir toxicidad con alteración del…”
    Get full text
    Journal Article